The Role of Colony-Stimulating Factors in Bone Marrow Transplantation

References

• Thomas E D, Storb R, Clift RA, et al. Bone-marrow transplantation (first of two parts). N Engl J Med 1975; 292: 832–843
   PubMed Web of Science ®Google Scholar
• Goldstone AH. Autologous bone marrow transplantation. Clin Haematol 1988; 15(1)1–256
   Google Scholar
• Sheridan W P, Fox R M, Boyd A, Morstyn G. Autologous bone marrow transplantation: present status and future prospects. Aust NZ J Med 1987; 17: 275–278
   PubMedGoogle Scholar
• To L B, Haylock D N, Kimber R J, Juttner CA. High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation. Br J Haematol 1984; 58: 399–410
   PubMed Web of Science ®Google Scholar
• Juttner C A, To L B, Haylock DN, et al. Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br J Haematol 1985; 61: 739–745
   PubMed Web of Science ®Google Scholar
• To L B, Dyson P G, Banford A, et al. Peripheral blood stem cells collected in very early remission produce rapid and sustained autologus hematopoietic reconstitution in acute non-lymphoblastic leukaemia. Bone Marrow Transplant 1987; 2: 103–108
   PubMed Web of Science ®Google Scholar
• Kessinger A, Armitage J O, Landmark JD, et al. Autologous peripheral haematopoietic stem cell transplantation restores function following marrow ablative therapy. Blood 1988; 71: 723–727
   PubMed Web of Science ®Google Scholar
• Watanabe T, Takaue Y, Kawano Y, et al. Peripheral blood stem cell autotransplantation in treatment of childhood cancer. Bone Marrow Transplant 1989; 4: 261–265
   PubMed Web of Science ®Google Scholar
• Hill R S, Mazza P, Amos D, et al. Engraftment in 86 patients with lymphoid malignancy after autologous marrow transplantation. Bone Marrow Transplant 1989; 4: 69–74
   PubMed Web of Science ®Google Scholar
• Harrington D S, Peterson C, Ness M, et al. Acute myelogenous leukemia and eosinophilic differentiation and trisomy 1. Am J Clin Pathol 1988; 90: 464–469
   PubMed Web of Science ®Google Scholar
• Gulati S C, Shank B, Black P, et al. Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J Clin Oncol 1988; 6: 1303–1313
   PubMed Web of Science ®Google Scholar
• Appelbaum F R, Herzig G P, Ziegler JL, et al. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978; 52: 85–95
   PubMed Web of Science ®Google Scholar
• Sheridan W P, Boyd A W, Green MD, et al. High dose chemotherapy with busulphan and cyclophosphamide and bone marrow transplantation for drug-sensitive malignancies in adults: a preliminary report. Med J Aust 1989; 151: 379–386
   PubMed Web of Science ®Google Scholar
• Kirk JL, Jr, Greenfield R A, Slease R B, Epstein RB. Analysis of early infectious complications after autologous bone marrow transplantation. Cancer 1988; 62: 2445–2450
   PubMed Web of Science ®Google Scholar
• Metcalf D. The molecular biology and cloning of the granulocyte-macrophage colony-stimulating factors. Blood 1986; 67: 257–274
   PubMed Web of Science ®Google Scholar
• Metcalf D. Haemopoietic growth factors 1. Lancet 1989; 1: 825–827
   PubMed Web of Science ®Google Scholar
• Morstyn G, Burgess AW. Hemopoietic growth factors: a review. Cancer Res 1988; 48: 5624–5637
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S, Buescher S, LeMaistre A, et al. Stimulaton of myelopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1988; 72: 134–141
   PubMed Web of Science ®Google Scholar
• Antin J H, Smith B R, Holmes W, Rosenthal DS. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 1988; 72: 705–713
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S, Buescher S, Broxmeyer HE, et al. Stimulation of myelopoiesis in patients with aplastic anaemia by recombinant human granulocyte-macrophage colony-stimulating factor. N Engl J Med 1988; 319: 1628–1634
   PubMed Web of Science ®Google Scholar
• Ganser A, Völkers B, Greher J, et al. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes—a phase I/II trial. Blood 1989; 73: 31–37
   PubMed Web of Science ®Google Scholar
• Ganser A, Ottrnann O G, Schulz G, Hoelzer D. Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine arabinoside in patients with myelodysplastic syndrome. A pilot study. Onkologie 1989; 12: 13–15
   PubMed Web of Science ®Google Scholar
• Aglietta M, Piacibello W, Sanavio F, et al. Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macropahge colony-stimulating factor. J Clin Invest 1989; 83: 551–557
   PubMed Web of Science ®Google Scholar
• Champlin R E, Nimer S D, Ireland P, et al. Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor. Blood 1989; 73: 694–699
   PubMed Web of Science ®Google Scholar
• Herrmann F, Schulz G, Lindemann A, et al. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor. J Clin Oncol 1989; 7: 159–167
   PubMed Web of Science ®Google Scholar
• Lieschke G J, Maher D, Cebron J, et al. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. An Intern Med 1989; 110: 357–364
   PubMed Web of Science ®Google Scholar
• Thompson J A, Lee D J, Kidd P, et al. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: Toxicity, pharmacokinetics, and hematological effects. J Clin Oncol 1989; 7: 629–637
   PubMed Web of Science ®Google Scholar
• Steward W P, Scarffe J H, Austin R, et al. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions—a phase I dose-toxicity study. Br J Cancer 1989; 59: 142–145
   PubMed Web of Science ®Google Scholar
• Phillips N, Jacobs S, Stoller R, et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma. Blood 1989; 74: 26–34
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S, Broxmeyer H E, Spitzer G, et al. Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome. Blood 1989; 74: 1491–1498
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle F, Lord J AD, Whitmore DN. Treatment of RAEB-t with intensive chemotherapy and GM-CSF. Leuk Res 1989; 13: 605–607
   PubMed Web of Science ®Google Scholar
• Lieschke G J, Maher D, O'Connor M, et al. Phase I study of intravenously administered bacterially synthesized granulocytemacrophage colony-stimulating factor and comparison with subcutaneous administration. Cancer Res 1990; 50: 606–614
   PubMed Web of Science ®Google Scholar
• Villeval J-L, Duhrsen U, Morstyn G, Metcalf D. Effect of recombinant human granulocyte-macrophage colony stimulating factor on progenitor cells in patients with advanced malignancies. Br J Haematol 1990; 74: 36–44
   PubMed Web of Science ®Google Scholar
• Socinski M A, Cannistra S A, Elias A, et al. Granulocyte-macrophage colony-stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988; 1: 1194–1198
   PubMed Web of Science ®Google Scholar
• Monroy R L, Skelly R R, MacVitte TJ, et al. The effect of recombinant human GM-CSF on recovery of monkeys transplanted with autologous bone marrow. Blood 1987; 70: 1696–1699
   PubMed Web of Science ®Google Scholar
• Nienhuis A W, Donahue R E, Karlsson S, et al. Recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest 1987; 80: 573–577
   PubMed Web of Science ®Google Scholar
• Butturini A, De Souza P C, Gale RP, et al. Use of recombinant granulocyte-macrophage colony stimulating factor in the Brazil radiation accident. Lancet 1988; 2: 471–474
   PubMed Web of Science ®Google Scholar
• Brandt S J, Peters W P, Atwater SK, et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988; 318: 869–875
   PubMed Web of Science ®Google Scholar
• Nemunaitis J, Singer J W, Buckner CD, et al. Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 1988; 72: 834–836
   PubMed Web of Science ®Google Scholar
• Blazar B R, Kersey J H, McGlave PB, et al. In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts. Blood 1989; 73: 849–857
   PubMed Web of Science ®Google Scholar
• Devereaux S, Linch D C, Gribben JG, et al. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease. Bone Marrow Transplant 1989; 4: 49–54
   PubMed Web of Science ®Google Scholar
• Gianni A M, Siena S, Bregni M, et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; 2: 580–585
   PubMed Web of Science ®Google Scholar
• Peters W P, Kurtzberg J, Kirkpatrick G, et al. GM-CSF primed peripheral blood progenitor cells (PBPC) coupled with autologous bone marrow transplantation (ABMT) will eliminate absolute leukopenia following high dose chemotherapy. Blood 1989; 74: 50a, sup, abstr
   Google Scholar
• De Witte T, Gratwohl A, Van der Lely N, et al. A multicenter double blind randomized trial of recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in recipients of allogeneic T-cell depleted bone marrow. Blood 1989; 74: 84a, sup, abstr
   Google Scholar
• Vose J M, Bierman P J, Kessinger A, et al. The use of recombinant human granulocyte-macrophage colony stimulating factor (rHu GM-CSF) for delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies. Blood 1989; 74: 283a, sup, abstr
   Google Scholar
• Peters W P, Stuart A, Affronti ML, et al. Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans. Blood 1988; 72: 1310–1315
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Zarth A, Gratwohl A, et al. Granulocyte-macrophage colony-stimulating factor for granulocyte defects of bone marrow transplant patients. Lancet 1989; 1: 494–494
   PubMed Web of Science ®Google Scholar
• Bronchud M H, Scarffe J H, Tatcher N, et al. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987; 56: 809–813
   PubMed Web of Science ®Google Scholar
• Morstyn G, Campbell L, Souza LM, et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667–672
   PubMed Web of Science ®Google Scholar
• Gabrilove J L, Jakubowski A, Scher H, et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988; 318: 1414–1422
   PubMed Web of Science ®Google Scholar
• Morstyn G, Campbell L, Duhrsen U, et al. Clinical studies with granulocyte colony stimulating factor (G-CSF) in patients receiving cytotoxic chemotherapy. Behring Inst Mitt 1988; 83: 234–239
   PubMedGoogle Scholar
• Glaspy J A, Baldwin G C, Robertson PA, et al. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Ann Inter Med 1988; 109: 789–795
   PubMed Web of Science ®Google Scholar
• Jakubowski A A, Souza L, Kelly F, et al. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med 1989; 320: 38–42
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Okabe T, Ozawa K, et al. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: A preliminary report. Am J Med 1989; 86: 178–182
   PubMed Web of Science ®Google Scholar
• Hammond W P, Price T H, Souza L M, Dale DC. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 1989; 320: 1306–1311
   PubMed Web of Science ®Google Scholar
• Bonilla M A, Gillio A P, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989; 320: 1574–1580
   PubMed Web of Science ®Google Scholar
• Takaue Y, Koyama T, Watanabe T, et al. In vivo dose-response effect of recombinant human granulocyte colony-stimulating factor on increase in granulocytes after peripheral blood stem cell autotransplantation. Acta Haematol (Basel) 1989; 81: 210–212
   PubMed Web of Science ®Google Scholar
• Kerrigan D P, Castillo A, Foucar K, et al. Peripheral blood morphologic changes after high-dose antineoplastic chemotherapy and recombinant human granulocyte colony-stimulating factor administration. Am J Clin Pathol 1989; 92: 280–285
   PubMed Web of Science ®Google Scholar
• Bronchud M H, Howell A, Crowther D, et al. The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer 1989; 60: 121–125
   PubMed Web of Science ®Google Scholar
• Teshima H, Ishikawa J, Kitayama H, et al. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study. Exp Hematol 1989; 17: 853–858
   PubMed Web of Science ®Google Scholar
• Morstyn G, Campbell Lieschke L. G., et al. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol 1989; 7: 1554–1562
   PubMed Web of Science ®Google Scholar
• Duhrsen U, Villeval J L, Boyd J, et al. Effects of recombinant granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074–2081
   PubMed Web of Science ®Google Scholar
• Welte K, Bonilla M A, Gillio AP, et al. Recombinant human granulocyte colony-stimulating factor: in vivo effects on myelopoiesis in primates. Behring Inst Mitt 1988; 83: 102–106
   PubMedGoogle Scholar
• Schuening F G, Storb R, Goehle S, et al. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood 1989; 74: 1308–1313
   PubMed Web of Science ®Google Scholar
• Storb R, Raff R F, Appelbaum FR, et al. What radiation dose for DLA-identical canine marrow grafts (published erratum appears. Blood Feb, 1989; 73(2)624, Blood, 72, 1300–1304, 1988
   Google Scholar
• Sheridan W P, Morstyn G, Wolf M, et al. Granulocyte colony stimulating factor (G-CSF) and neutrophil recovery following high dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891–895
   PubMed Web of Science ®Google Scholar
• Masaoka T, Takaku F, Kato S, et al. Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation. Exp Hematol 1989; 17: 1047–1050
   PubMed Web of Science ®Google Scholar
• Peters WP, Kurtzberg J, Atwater S, et al. Comparative effects of rHuG-CSF and rHuGM-CSF on hematopoietic reconstitution and granulocyte function following high dose chemotherapy and autologous bone marrow transplantation (ABMT). Blood 1988; 72: 130a, abstr
   Google Scholar
• Taylor K, Spitzer G, Jagannath, et al. Phase II study of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in Hodgkin's disease after high-dose chemotherapy with ABMT. Blood 1988; 72: 135a, abstr
   Google Scholar
• Kodo H, Tajika K, Takahashi S, et al. Acceleration of neutrophilic granulocyte recovery after bone marrow transplantation by administration of recombinant human granulocyte colony-stimulating factor. Lancet 1988; 2: 38–39
   PubMed Web of Science ®Google Scholar
• Toner G C, Jakubowski A A, Crown J PA, et al. Preservation of localized leukocyte mobilization (LLM) in patients receiving recombinant human granulocyte colony-stimulating factor. Blood 1988; 72: 154a, abstr
   Google Scholar
• Donahue R E, Seehra J, Metzger M, et al. Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 1988; 241: 1820–1822
   PubMed Web of Science ®Google Scholar
• Ferrero D, Tarella C, Badoni R, et al. Granulocyte-macrophage colony-stimulating factor requires interaction with accessory cells or granulocyte-colony stimulating factor for full stimulation of human myeloid progenitors. Blood 1989; 73: 402–405
   PubMed Web of Science ®Google Scholar
• Saeland S, Caux C, Favre C, et al. Combined and sequential effects of human IL-3 and GM-CSF on the proliferation of CD34+ hematopoietic cells from cord blood. Blood 1989; 73: 1195–1201
   PubMed Web of Science ®Google Scholar
• McNiece I, Andrews R, Stewart M, et al. Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: Synergistic interaction of GM-CSF plus G-CSF. Blood 1989; 74: 110–114
   PubMed Web of Science ®Google Scholar
• Hara H, Namiki M. Mechanism of synergy between granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in colony formation from human marrow cells in vitro. Exp Hematol 1989; 17: 816–821
   PubMed Web of Science ®Google Scholar